1. Murray BE, Miller WR. Treatment of enterococcal infections. Uptodate. 2021. (Consultado el 28/06/2021 en https://bit.ly/3tJuU3b)
2. Rodríguez-Baño J, Gutiérrez-Gutiérrez B, Machuca I, Pascual A. Treatment of Infections Caused by Extended Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing
3. Enterobacteriaceae. Clinical Microbiology Reviews. 2018; 31(2).
4. Meini S, Tascini C, Cei M, Sozio E, Rossolini G. AmpC β-lactamase-producing Enterobacterales: what a clinician should know. Infection. 2019; 47(3):363-375.
5. Cheng M, Lee R, Cheng A, De L’étoile-Morel S, Demir K, Yansouni C et al. Beta-Lactam/Beta-Lactamase Inhibitor Therapy for Potential AmpC-Producing Organisms: A Systematic
6. Review and Meta-Analysis. Open Forum Infectious Diseases. 2019; 6(7).
7. Nation R, Garonzik S, Thamlikitkul V, Giamarellos-Bourboulis E, Forrest A, Paterson D et al. Dosing guidance for intravenous colistin in critically-ill patients. Clinical Infectious Diseases. 2017:64(5):565–71
8. Mensa J, Soriano A, López-Suñe E, Llinares P, Zboromyrska Y, Bareberán J. Guía de terapéutica antimicrobiana 2021. Ed. Antares. 2021. |
